Related Experiment Video
Updated: Jan 8, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Anaerobiospirillum succiniciproducens Community-Acquired Pneumonia With Bacteraemia in an Immunocompetent Individual
Thomas Ledger1, Varun Moorthy1, Dean Panos1
1Department of Infectious Diseases, Blacktown Hospital, Western Sydney Local Health District, Blacktown, New South Wales, Australia.
Abstract:
An independent 69-year-old diagnosed with community-acquired pneumonia presented with Anaerobiospirillum succiniciproducens bacteraemia, initially identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry. A rarely reported cause of pneumonia and bacteraemia, it is considered a zoonotic bacterium from cats and dogs. She was treated successfully with piperacillin/tazobactam and amoxicillin/clavulanic acid.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
08:25Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Bacterial Phylum Spirochaetes
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Phylum Tenericutes